CD40 Ligand Antikörper

Produktnummer ABIN135219

Der Hamster Monoklonal anti-CD40 Ligand Antikörper (Klon MR1) (ABIN135219) detektiert spezifisch CD40 Ligand in FACS, IP, ELISA, BR und IHC (fro). Dieser Antikörper reagiert spezifisch mit Proben aus Maus.

Kurzübersicht für CD40 Ligand Antikörper (ABIN135219)

Target: CD40 Ligand (CD40LG)

Reaktivität: Maus

Wirt: Hamster

Klonalität: Monoklonal

Konjugat: Dieser CD40 Ligand Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Immunoprecipitation (IP), ELISA, Blocking Reagent (BR), Immunohistochemistry (Frozen Sections) (IHC (fro))

Klon: MR1

Produktdetails anti-CD40 Ligand Antikörper

Verwendungszweck: Hamster Anti-Mouse CD154-LE/AF

Spezifität: Mouse CD154, Mr 39 kDa

Produktmerkmale: Low Endotoxin/Azide Free Anti-Mouse CD154 antibody for use in flow cytometry, immunohistochemistry, immunoprecipitation, ELISA, and blocking assays.

Endotoxin-Niveau: Low Endotoxin

Immunogen: Activated mouse Th1 clone D1.6

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Phosphate buffered saline, pH 7.4

Konservierungsmittel: Azide free

Handhabung: Each reagent is stable for the period shown on the bottle label if stored as directed.

Lagerung: 4 °C

Informationen zur Lagerung: 2-8°C

Details zu CD40 Ligand

Target: CD40 Ligand (CD40LG)

Andere Bezeichnung: CD154

Hintergrund: CD154, formerly known as CD40 ligand and gp39, is a type II integral membrane protein and a member of the tumor necrosis factor (TNF) family of ligands. It is an important accessory molecule in T cell-B cell costimulatory interactions, and is expressed predominantly on activated CD4+ T lymphocytes. It is also present on the surface of activated Th0, Th1, and Th2 T cell clones. Its expression is transient and cyclosporin-sensitive.

Gen-ID: 21947

UniProt: P27548

Pathways: NF-kappaB Signalweg, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints